Veterans with certain conditions would get access to new experimental treatments through a VA program.
This bill would create a new program at the Department of Veterans Affairs (VA) to research and offer experimental treatments for veterans. It aims to give veterans more options for conditions like chronic pain, PTSD, or anxiety that currently lack effective treatments. The program would include clinical trials and potentially early access to new therapies.
Today, the Department of Veterans Affairs (VA) does not have a specific program dedicated to investigational research and extended access for innovative treatments and emerging therapies for conditions like chronic pain or PTSD. If this bill becomes law, the VA would be directed to establish such a program within 90 days, allowing veterans with certain conditions to participate in clinical trials or be considered for early access to new therapies.
HR 7091 · 119th Congress · January 15, 2026 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
7 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.